A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase

Andrea C. Mislak; Kathleen M. Frey; Mariela Bollini; William L. Jorgensen; Karen S. Anderson

doi:10.1016/j.bbagen.2014.04.001

Back

A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase

Article 2014 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1995

Oxathiin Carboxanilide Derivatives: A Class of Non-Nucleoside HIV-1-Specific Reverse Transcriptase Inhibitors (NNRTIs) that are Active against Mutant HIV-1 Strains Resistant to other NNRTIs

Jan Balzarini, Heidi Jonckheere, WilliamO. Harrison, D.C. Dao, Jozef Anné, De Clercq Erik, Anna Karlsson

Article2014

Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors

Shuang‐Xi Gu, Yuan‐Yuan Zhu, Fen‐Er Chen, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2020

Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C

Ping Gao, Shu Song, Estrella Frutos-Beltrán, Wenxin Li, Bin Sun, Dongwei Kang, Jinmi Zou, Jian Zhang, Christophe Pannecouque, De Clercq Erik, Luis Menéndez‐Arias, Peng Zhan, Xinyong Liu

Article2019

Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment

Yali Wang, De Clercq Erik, Guangdi Li

Article2013

Structure‐Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting <scp>HIV</scp>‐1 Reverse Transcriptase

Kathleen M. Frey, William T. Gray, Krasimir A. Spasov, Mariela Bollini, Ricardo Gallardo‐Macias, William L. Jorgensen, Karen S. Anderson

Chemical Biology & Drug Design